Adam Crystal

President, R&D, Tango Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$7.0M

Companies

Latest trade

Oct 1, 2026

Companies

Tango Therapeutics, Inc.President, R&D −$7.0M

Trades

TNGX Sold 27,000 shares at $24.47 · planned $0.7M Oct 1

TNGX Sold 27,000 shares at $22.37 · planned $0.6M Sep 1

TNGX Sold 27,000 shares at $27.24 · planned $0.7M Aug 3

TNGX Sold 27,000 shares at $29.59 · planned $0.8M Jul 1

TNGX Sold 27,000 shares at $22.88 · planned $0.6M Jun 1

TNGX Sold 27,000 shares at $21.22 · planned $0.6M May 1

TNGX Sold 38,460 shares at $25.00 · planned $1.0M Apr 15

TNGX Sold 27,000 shares at $21.20 · planned $0.6M Apr 1

TNGX Sold 12,000 shares at $20.11 · planned $0.2M Mar 25

TNGX Sold 20,251 shares at $15.00 · planned $0.3M Mar 5

TNGX Sold 54,345 shares at $12.77 · planned $0.7M Feb 25

TNGX Sold 18,452 shares at $12.27 $0.2M Feb 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.